NCT00915915 - Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD) | Biotech Hunter

Enrollment

108

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions

ContraceptionOvulation Inhibition

Interventions

DRUG

Ethinylestradiol/Gestodene (BAY86-5016)

Transdermal patch: 0.55mg Ethinylestradiol (EE+2.1mg GSD)Gestodene; 3x7 days patch- wearing phase and a patch-free interval of 7 days (1 pre-treatment cycle, 3 treatment cycles), 1 Follow - up cycle)

DRUG

Ethinylestradiol/Gestodene (BAY86-5016)

Transdermal patch: 0.55mg Ethinylestradiol (EE+1.05mg GSD)Gestodene; 3x7 days patch- wearing phase and a patch-free interval of 7 days (1 pre-treatment cycle, 3 treatment cycles), 1 Follow - up cycle)

Trial Locations (2)

10115

Berlin

13353

Berlin